GMEDGlobus Medical Inc
Compact View
Earnings Recap
• Reported GAAP EPS of $0.92 up 67.27% YoY • Reported revenue of $759.85M up 27.04% YoY • Globus Medical reaffirms its full-year 2026 revenue guidance of $3.18B to $3.22B and updated non-GAAP diluted EPS guidance to $4.70 to $4.80, raised from $4.40 to $4.50.
Bullish
Globus Medical achieved strong worldwide net sales growth of 27.0% and a 66.6% increase in GAAP diluted EPS. The company also drove margin expansion through disciplined execution and operating leverage on higher volumes.
Bearish
Globus Medical faces ongoing Nevro integration costs and challenges, with increased acquisition-related expenses. Additionally, the company experienced a foreign currency transaction loss, and base business growth was significantly lower than overall sales growth.